Standout Papers

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs 2020 2026 2022 2024439
  1. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs (2020)
    Sangeun Jeon, Meehyun Ko et al. Antimicrobial Agents and Chemotherapy

Immediate Impact

2 from Science/Nature 51 standout
Sub-graph 1 of 25

Citing Papers

Long COVID: a clinical update
2024 Standout
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
2024 Standout
2 intermediate papers

Works of Inhee Choi being referenced

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
2021
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
2020 Standout

Author Peers

Author Last Decade Papers Cites
Inhee Choi 529 565 109 251 40 1.2k
Jun Takayama 381 557 91 277 41 1.2k
Sangeun Jeon 438 564 55 257 33 1.4k
Ingrid Choong 638 349 156 196 20 1.4k
Sonia Vega 646 415 67 258 55 1.4k
Shailendra Asthana 530 364 153 298 71 1.3k
Young-Hee Jin 399 367 118 109 79 1.5k
Ahmad Abu Turab Naqvi 491 579 74 277 23 1.2k
Ying‐Ta Wu 680 234 114 177 43 1.3k
Shiv Bharadwaj 421 386 112 320 46 1.5k
Sumra Wajid Abbasi 554 250 64 297 62 1.2k

All Works

Loading papers...

Rankless by CCL
2026